TRUPANION INC (TRUP)
Financials · specialized insurance · NASDAQ
Trupanion offers specialized, data-driven medical insurance for pets to help owners manage unpredictable veterinary expenses through a reliable subscription model.
What TRUPANION INC does
Trupanion provides medical insurance for cats and dogs in the United States, Canada, and Continental Europe through a data-driven, vertically-integrated subscription model. The company collects over 25 years of comprehensive pet health data to price individualized insurance products that help pet parents budget for unexpected veterinary expenses. Revenue is generated primarily through subscription payments from direct-to-consumer insurance products, with additional revenue from underwriting arrangements with third parties and employer-sponsored programs.
Themes: pet health insurance, subscription services, fintech / insurtech, veterinary services
Fundamentals
- Price$31.10 as of 2026-08-21 close
- Market cap$1.4B as of 2026-08-21
- 1-year return-34.8% 2025-08-21 close $47.73 → 2026-08-21 close $31.10
- P/E57.51 as of 2026-08-24
- Net margin+1.5% as of 2026-08-24
- Gross margin+16.6% as of 2026-08-24
- ROE+6.0% as of 2026-08-24
- Debt / equity0.26 as of 2026-08-24
- Revenue growth (YoY)+11.8% as of 2026-08-24
- Revenue CAGR (3y)+16.7% SEC XBRL
- Beta1.45 as of 2026-08-24
- Last reported earnings2026-08-05 SEC EDGAR Form 8-K (Item 2.02)
How TRUP compares in its sector
- price-to-earnings ratiotop 10% 525 covered Financials peers, as of 2026-08-24
- net profit marginbottom 25% 538 covered Financials peers, as of 2026-08-24
- operating marginbottom 25% 534 covered Financials peers, as of 2026-08-24
- gross marginbottom 10% 176 covered Financials peers, as of 2026-08-24
- return on equitybottom 25% 575 covered Financials peers, as of 2026-08-24
- 3-year revenue CAGRmiddle range 347 covered Financials peers
- free cash flow (absolute dollars, latest fiscal year)middle range 431 covered Financials peers, as of FY2025
Position among covered Financials companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
How TRUPANION INC looks technically
TRUPANION INC (TRUP) is trading 6.2% above its 200-day average, the long-term trend line — a longer-term uptrend. Its 50-day average crossed below its 200-day average about 205 trading days ago — a "death cross", a bearish long-term signal. A strong uptrend is in place — ADX, a 0–100 trend-strength gauge, is 34, with buyers in control. Momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 66, neither overbought (above 70) nor oversold (below 30). It made a new 20-day high about 3 trading days ago. It is 36.2% below its highest point of the past year.
Trend
9
| Distance from the 200-day | it is trading 6.2% above its 200-day average, the long-term trend line — a longer-term uptrend | +6.2% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $26.25 | $26.25 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $29.29 | $29.29 |
| Swing structure | its recent peaks and dips disagree — one of them is rising while the other is not, so there is no clean up or down pattern in the swings | mixed — one of the two is not confirming |
| Last swing turn | its last significant turn was a swing low 16 calendar days ago — the swings before that are what the structure reading is measured on | 16 sessions |
| Wave structure | its recent swings can be read as a completed three-part downward correction — a pullback in the A-B-C shape Elliott-wave chartists use; the labelling fails if price closes below 23.98. It is the only labelling that fits, though not with textbook proportions, and it describes the swings already printed, not what comes next. | possible three-wave downward correction, complete (atypical proportions) |
| Since the 50/200 cross | its 50-day average crossed below its 200-day average about 205 trading days ago — a "death cross", a bearish long-term signal | 205 sessions |
| Above the 200-day after a dip | it recently dipped to its 200-day average (the long-term trend line) and has since climbed back above it — now about 6.2% above | +6.2% |
| Trend strength (14-day ADX) | a strong uptrend is in place — ADX, a 0–100 trend-strength gauge, is 34, with buyers in control | 33.7 |
Momentum
3
| 14-day RSI | momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 66, neither overbought (above 70) nor oversold (below 30) | 65.7 |
|---|---|---|
| Position in its 14-day range | it is trading near the top of its 14-day range ($23.98 to $31.48) — its "stochastic" reading is 95 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been climbing within that range over the last few sessions. | 94.9 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, is in positive territory (momentum leaning bullish) | 12 sessions |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $48.78 | $48.78 |
|---|---|---|
| From the 52-week high | it is 36.2% below its 52-week high (its highest price of the past year) | -36.2% |
| Above the 52-week low | it is 47.0% above its 52-week low (its lowest price of the past year) | +47.0% |
| Below the 52-week high | it is 36.2% below its highest point of the past year | 36.2% |
| Since a 20-day breakout | it made a new 20-day high about 3 trading days ago | 3 sessions |
| Since a 55-day breakout | it made a new 55-day high about 3 trading days ago | 3 sessions |
| All-time high | its highest closing price on record is $158.25 (set on 2021-12-08) | $158.25 |
| Given back of the 52-week move | over the past year its closes ranged ($21.46 to $47.98), and it has recovered roughly a third of its fall from last year’s high — 36% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $37.85 to $38.70. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 36.4% |
| From the all-time high | it is 80.3% below its all-time high | -80.3% |
| Nearest price level | it is sitting right on a support level at $30.96 — a price it turned at five times since 2025-02-24, most recently on 2026-02-03. Since 2024-08-21 it has 4 such levels below the current price and 10 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | -0.5% |
| All-time low | its lowest closing price on record is $5.21 (set on 2014-12-16) | $5.21 |
| Above the all-time low | it is 496.9% above its all-time low | +496.9% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are unusually wide versus its own recent history (wider than about 96% of the past ~6 months) | 96th percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $1.28 between its high and its low — about 4.1% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $1.28 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $22.59 and $33.28 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $22.59 – $27.93 – $33.28 |
| Typical daily range (% of price) | its price moves about 4.1% in a typical session — about typical for the companies we cover. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 4.1% |
| Stretch from the 200-day average | it is trading 1.4 daily ranges above its 200-day average price (6.2% above it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 1.4 daily ranges above its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is about normal versus its 30-day average | 0.66× |
|---|
Analyst
2
| Change in the average price target | analysts' average price target is unchanged from the prior reading | 0.0% |
|---|---|---|
| Change in the consensus rating | the analyst consensus rating is unchanged since the prior reading | unchanged |
Candlestick patterns
2
| Since a bullish engulfing | 9 sessions ago it opened below the previous session's close and finished above that session's open — a "bullish engulfing" pair, where one up day more than undid the down day before it | 9 sessions ago |
|---|---|---|
| Since a bearish engulfing | 5 sessions ago it opened above the previous session's close and finished below that session's open — a "bearish engulfing" pair, where one down day more than undid the up day before it | 5 sessions ago |
Price gaps
3
| Gap at the open | it opened on 2026-08-21 0.3% above the previous session's close — an overnight gap, the part of the move that happened while the market was shut, and traded back through that level before the close | +0.3% |
|---|---|---|
| Open gap | it gapped 13.1% above the previous close 11 sessions ago and has not traded back through the level it left behind at 24.39 — an "unfilled gap", which describes a price range no trade has since crossed and is not a forecast that it will be crossed | +13.1% |
| Gap filled | a 2.1% gap down opened on 2026-08-04 has been "filled" 13 sessions ago — price traded back through the level the gap left behind, and it closed again during the very session that opened it | 13 sessions ago |
Price streaks
1
| Closing streak | it closed higher in its latest session, after a session that did not close higher — a single up day rather than a run | 1 session up |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock beat the market by 18.0 percentage points (the stock gained 20.3% while the market gained 2.3%) | +18.0% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock beat the market by 39.2 percentage points (the stock gained 42.3% while the market gained 3.1%) | +39.2% |
| vs market, 6 months | over the past 6 months this stock lagged the market by 4.0 percentage points (the stock gained 7.0% while the market gained 11.1%) | -4.0% |
| vs market, 12 months | over the past 12 months this stock lagged the market by 55.3 percentage points (the stock lost 34.8% while the market gained 20.5%) | -55.3% |
Signal agreement
2
| Bullish technical signals | 5 of the 9 technical signals we can compute for it are currently in a bullish state: a strong uptrend, with buyers in control, trading above its 200-day average, a fresh 20-day high, MACD momentum is positive, trading above the Ichimoku cloud — these describe past price behaviour, not a forecast | 5 of 9 |
|---|---|---|
| Bearish technical signals | 3 of the 9 technical signals we can compute for it are currently in a bearish state: a "death cross" — its 50-day average is below its 200-day, lagging the market over 6 months, near the top of its 14-day range (overbought) — these describe past price behaviour, not a forecast | 3 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading 22% above the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-07-16 and projected forward over today's price, the side traders read as an established uptrend, with the band below acting as the level that would have to give way. The band itself is moderate, spanning 3.3% of the share price. | +22.5% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is 13% above the average price paid so far this year, so the typical buyer over that stretch is showing a gain. That average is $27.40 — a volume-weighted average of daily closes over 158 sessions, not a true tick-by-tick VWAP. | +13.5% |
|---|---|---|
| Vs the average paid since it last reported | the price is 6% above the average price paid since it last reported on 2026-08-05 (its 10-Q), so the typical buyer over that stretch is showing a gain. That average is $29.27 — a volume-weighted average of daily closes over 13 sessions, not a true tick-by-tick VWAP. | +6.3% |
Price levels it has turned at before
TRUP last closed at $31.10 on 2026-08-21. Since 2024-08-21 it has turned at 4 prices below its last close and 10 above; the 3 nearest below and the 3 nearest above are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $30.96 | Support | 0.5% below the last close | turned there five times · 2025-02-24 to 2026-02-03 |
| $29.24 | Support | 6.0% below the last close | turned there twice · 2026-03-05 to 2026-04-21 |
| $34.44 | Resistance | 10.7% above the last close | turned there twice · 2026-01-06 to 2026-02-10 |
| $24.23 | Support | 22.1% below the last close | turned there twice · 2026-03-19 to 2026-04-13 |
| $38.79 | Resistance | 24.7% above the last close | turned there five times · 2025-03-25 to 2025-12-31 |
| $40.27 | Resistance | 29.5% above the last close | turned there twice · 2024-10-01 to 2025-10-13 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
Its recent swings can be read as a three-part downward correction — the A-B-C shape chartists use for a pullback — now complete.
This labelling fails — stops being a possible reading at all — if it closes below $23.98.
It is the only labelling that fits these swings, though its proportions are not the textbook ones. It was chosen from 3 labellings that survived the rules, counting shorter readings of the same bars.
This labelling was already in place when we began recording count changes on 2026-08-13, so how long it has stood is not something we can say yet.
Read from daily closes as of 2026-08-21.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading above the 200-day moving average · Tested and reclaimed 200-day support · Pulled back from the 12-month high · Broke out to a new 20-day high · in a strong, established uptrend (ADX) · At the top of its 14-day range (stochastic above 80) | Learn: moving average · golden cross · adx · rsi · breakout · fifty two week high low
Based on daily closing prices as of 2026-08-21. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Consensus ratingBuy (2.17 mean, 1=Strong Buy…5=Strong Sell) — 4 analysts
- Mean price target$37.25 range $28.00 – $45.00; median $38.00
Analyst estimates, as of 2026-08-17. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Analyst EPS estimate for TRUP
- Consensus EPS estimate$0.98 next reporting period, as of 2026-08-17
Change over time is not available yet: it needs two readings of the same reporting period at least 30 days apart, and we have been recording these estimates since 2026-08-04. An estimate for a DIFFERENT quarter is not a revision, so a reading from before the last report is never compared with one after it.
The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.
Key risks (from latest filing)
["High competitive pressure in the pet insurance industry from both established insurers and new entrants.","Dependency on veterinary invoice expenses which can be volatile and difficult to predict.","Potential for adverse effects from changes in veterinary care costs and advancements in medical procedures."]
What changed in the latest 10-Q
AI-assisted comparison of TRUP's 10-Q filed 2026-04-30 against the prior one filed 2025-11-06.
Management's Discussion & Analysis (MD&A)
- Added:
- Newer filing (2026-04-30) adds eight-quarter comparison table starting from Q2 2024, including Mar. 31, 2026 data with Total pets enrolled of 1,637,665 and subscription pets of 1,105,783
- Newer filing adds Monthly average revenue per pet of $85.79 for Q1 2026 and Average PAC of $315 for Q1 2026
- Newer filing adds Average monthly retention of 98.35% for Q1 2026
- Newer filing includes clarification that per pet metrics exclude European policies where revenue is earned from commissions rather than subscription payments
- Removed:
- Older filing (2025-11-06) included year-to-date nine months ended September 30 table comparing 2025 to 2024; newer filing removes this comparative year-to-date table
- Older filing included data through Dec. 31, 2023 in the eight-quarter table; newer filing's eight-quarter table ends at Jun. 30, 2024
- Removed statement: 'Going forward our intent is to assume full insurance risk for these products, either through direct underwriting or reinsurance arrangements' from Continental Europe product description
- Removed reference to 'Pets Best Insurance Services' full legal name, now referred to simply as 'Pets Best'
- Removed phrase 'Going forward, we expect that enrollment from Pets Best will continue to decline as it engages other third-party underwriters'; now states only 'We expect that enrollment from Pets Best will continue to decline as it engages other third-party underwriters'
- Removed 'a significantly lower margin profile than our subscription segment' descriptor; newer filing states only 'a significantly lower margin profile than our subscription business segment'
- Reworded:
- Changed 'insurance premiums, which we refer to as subscription payments, from direct-to-consumer products' (older) to 'insurance premiums, which we refer to as subscription payments from direct-to-consumer products' (newer) - minor punctuation adjustment
- Changed 'leads from third-parties such as veterinarians and referrals from existing members' (older) to 'referrals from third-parties such as veterinarians and existing members' (newer) - reordering of referral source description
- Changed 'pet owner education' (older) to 'pet parent education' (newer)
- Changed 'and is not part of our core business strategy. The largest source' (older) to 'and is not part of our core business strategy. The largest source' (newer) - contextual change where 'a significantly lower' replaced 'a lower' in margin profile descriptor
- Changed table header from 'The following tables set forth' (older, plural) to 'The following table sets forth' (newer, singular) - reflecting removal of year-to-date table
- Changed 'one of the insurance products offered in our subscription business segment and our other business segment' (older) to 'one of the insurance products offered in our subscription business segment or our other business segment' (newer) - changed 'and' to 'or'
- Notes:
- The older filing's narrative section appears truncated at 'Average monthly retention is measured as...' while the newer filing also appears truncated mid-sentence; full comparison of retention metric definition may not be fully assessable
- The year-to-date table removal in the newer filing represents a substantive restructuring of presented metrics rather than a textual change to existing language
Risk Factors
- Added:
- Newer filing (2026-04-30) references Annual Report on Form 10-K for fiscal year ended December 31, 2025 filed February 13, 2026
- Newer filing covers three months ended March 31, 2026 with revenue of $384,049 thousand
- Newer filing shows net income of $4,880 thousand for Q1 2026
- Newer filing reports March 31, 2026 balance sheet data including cash of $153,456 thousand
- Newer filing shows diluted EPS of $0.11 for Q1 2026
- Removed:
- Older filing (2025-11-06) references Annual Report on Form 10-K for fiscal year ended December 31, 2024 filed February 27, 2025
- Older filing covered three months and nine months ended September 30, 2025
- Older filing reported nine-month net income of $13,803 thousand through September 30, 2025
- Older filing showed September 30, 2025 balance sheet data including cash of $154,773 thousand
- Older filing contained statement 'Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee that the future results...' and 'We undertake no obligation to update publicly any forward-looking statements for any reason, except as required by law'
- Older filing included comprehensive income statement for nine months ended September 30, 2025
- Reworded:
- Forward-looking statements section modified: removed reference to 'Section 21E of the Securities Exchange Act of 1934, as amended ("Exchange Act"), and Section 27A of the Securities Act of 1933, as amended ("Securities Act")' and removed phrase 'All statements contained in this Quarterly Report on Form 10-Q other than statements of historical fact, including statements regarding our future results of operations and financial position, our business strategy and plans and our objectives for future operations, are forward-looking statements'
- Forward-looking statements section simplified: removed phrase 'Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee that the future results, levels of activity, performance or events and circumstances reflected in the forward-looking statements will be achieved or occur'
- Notes:
- Comparison is limited to the provided excerpts; full Risk Factors sections not provided for detailed comparison
- Financial statements cover different periods (Q1 2026 vs. Q3 2025 and nine-month 2025), making period-to-period comparisons of operating metrics not directly comparable
- Text appears truncated in both filings at certain points
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
0 open-market purchases and 7 open-market sales by insiders in the last 90 days.
- Last 30 days0 buys · 2 sells ($39220) — 2 selling insiders
- Last 90 days0 buys · 7 sells ($412144) — 4 selling insiders
- Last 180 days0 buys · 10 sells ($445669) — 4 selling insiders
Activity heuristic: net selling (a transparent product heuristic from the counts above, not a prediction or advice)
Most recent open-market transaction: 2026-08-11. As of 2026-08-24.
View full insider trading history → View SEC Form 3/4/5 filingsAsk about TRUP's insider activity →
Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
Institutional ownership (13F)
5 institutional 13F filers reported holding TRUP as of 2026-03-31 (quarter-end position, filed within 45 days).
- Distinct 13F filers 5
- Reported shares held 8,232,749
- Reported value $210,840,698
reported quarterly holdings change (2025-12-31 → 2026-03-31): 0 new, 3 increased, 2 decreased, 1 exited. Change counts cover only managers that filed 13F reports in BOTH quarters, derived between two quarter-end snapshots — not same-day trades; a single manager is never said to have "bought" or "sold".
Institutional holdings are quarter-end long positions reported on SEC Form 13F-HR, filed up to 45 days after the quarter ends — they are delayed, are not real-time trades, exclude short positions and most non-US securities, and are not investment advice. Any increase/decrease is a reported change between two quarterly snapshots, not a same-day purchase or sale. These are quarter-end snapshots from the 13F filings on SEC EDGAR, filed within 45 days — not real-time, and any change is a difference between two quarterly reports, not a same-day trade. Informational only — not financial advice.
Short interest (FINRA)
TRUP had 3,718,120 shares of reported short interest as of the 2026-07-31 FINRA settlement date (delayed, bi-monthly; not real-time).
TRUP had 8.47% of its shares outstanding sold short as of the 2026-07-31 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 11.69 days to cover at the same settlement.
- Reported short interest (shares) 3,718,120
- Short interest (% of shares outstanding) 8.47%
- Prior settlement (shares) 3,707,932
- Reported change 0.27%
- Days to cover (reported) 11.69
Reported to FINRA as of the 2026-07-31 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- Nationwide Pet Insurance
- Healthy Paws Pet Insurance
- Petplan (Allianz)
- ASPCA Pet Health Insurance (Crum & Forster)
- Lemonade Pet (LMND)
- Embrace Pet Insurance
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare TRUP vs…
Frequently asked questions
What does TRUPANION INC (TRUP) do?
Trupanion provides medical insurance for cats and dogs in the United States, Canada, and Continental Europe through a data-driven, vertically-integrated subscription model. The company collects over 25 years of comprehensive pet health data to price individualized insurance products that help pet parents budget for unexpected veterinary expenses.
What sector is TRUPANION INC (TRUP) in?
TRUPANION INC (TRUP) is classified in the Financials sector. Its industry is specialized insurance. It trades on NASDAQ.
Who are TRUPANION INC's (TRUP) competitors?
Notable peers of TRUPANION INC (TRUP) include Nationwide Pet Insurance, Healthy Paws Pet Insurance, Petplan (Allianz), ASPCA Pet Health Insurance (Crum & Forster) and Lemonade Pet. This peer set is informational only — not financial advice.
Is TRUPANION INC (TRUP) overbought or oversold right now?
TRUPANION INC (TRUP) is currently neither overbought nor oversold — its 14-day RSI (a 0–100 momentum gauge) is 66, in the neutral middle (as of 2026-08-21). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on TRUP come from?
Fundamentals and prices come from market data, as of 2026-08-24; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: market data, as of 2026-08-24. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-21.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.